First Time Loading...

Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392

Watchlist Manager
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Logo
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Watchlist
Price: 68.65 CNY -2.25% Market Closed
Updated: May 8, 2024

Wall Street
Price Targets

Price Targets Summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Wall Street analysts forecast Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is 67.59 CNY with a low forecast of 51.82 CNY and a high forecast of 93.98 CNY.

Lowest
Price Target
51.82 CNY
25% Downside
Average
Price Target
67.59 CNY
2% Downside
Highest
Price Target
93.98 CNY
37% Upside
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors:
Price Targets
002030
Daan Gene Co Ltd
98% Upside
688278
Xiamen Amoytop Biotech Co Ltd
32% Upside
4893
Noile-Immune Biotech Inc
191% Upside
KYMR
Kymera Therapeutics Inc
36% Upside
6855
Ascentage Pharma Group International
59% Upside
SNSE
Sensei Biotherapeutics Inc
163% Upside
KNTE
Kinnate Biopharma Inc
9% Downside
300289
Beijing Leadman Biochemistry Co Ltd
248% Upside

Revenue
Forecast

Revenue Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is 41%. The projected CAGR for the next 3 years is 38%.

41%
Past Growth
38%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's operating income is 55%. The projected CAGR for the next 3 years is 67%.

55%
Past Growth
67%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is 34%. The projected CAGR for the next 2 years is 80%.

34%
Past Growth
80%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's stock price target?
Price Target
67.59 CNY

According to Wall Street analysts, the average 1-year price target for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is 67.59 CNY with a low forecast of 51.82 CNY and a high forecast of 93.98 CNY.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Revenue forecast?
Projected CAGR
38%

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is 41%. The projected CAGR for the next 3 years is 38%.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Operating Income forecast?
Projected CAGR
67%

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's operating income is 55%. The projected CAGR for the next 3 years is 67%.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Net Income forecast?
Projected CAGR
80%

For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is 34%. The projected CAGR for the next 2 years is 80%.